why choose us

First received: November 27, 2024

Clinical Trial: Study of HS235 for Assessing the Pharmacokinetics, Safety, and Pharmacodynamics in Overweight/Obese Healthy Subjects

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Overweight and Obesity

Study Type: INTERVENTIONAL


Official Title: Phase 1 Single and Multiple Ascending Dose Study in Males and Females Assessing the Pharmacokinetics, Safety, and Pharmacodynamics of HS235 in Overweight and Obese Otherwise Healthy Subjects

Brief Summary: Study of HS235 for Assessing the Pharmacokinetics, Safety, and Pharmacodynamics of HS235 in Overweight and Obese Otherwise Healthy Subjects

Read more